PatientsVille.com Logo

Glaucoma and Tildiem

PatientsVille

Glaucoma Symptoms and Causes

Glaucoma is a group of diseases that can damage the eye's optic nerve. It is a leading cause of blindness in the United States. It usually happens when the fluid pressure inside the eyes slowly rises, damaging the optic nerve. Often there are no symptoms at first. Without treatment, people with Glaucoma will slowly lose their peripheral, or side vision. They seem to be looking through a tunnel. Over time, straight-ahead vision may decrease until no vision remains.

A comprehensive eye exam can tell if you have Glaucoma. People at risk should get eye exams at least every two years. They include

  • African Americans over age 40
  • People over age 60, especially Mexican Americans
  • People with a family history of Glaucoma

There is no cure, but Glaucoma can usually be controlled. Early treatment can help protect your eyes against vision loss. Treatments usually include prescription eyedrops and/or surgery.

NIH: National Eye Institute

Check out the latest treatments for glaucoma

glaucoma treatment research studies

Tildiem clinical trials, surveys and public health registries


Find Drug Side Effect reports



Tildiem Side Effects

Bradycardia (20)
Musculoskeletal Stiffness (13)
Renal Failure (10)
Atrial Fibrillation (8)
Arthralgia (5)
Fall (5)
Renal Failure Acute (5)
Malaise (5)
Myalgia (4)
Overdose (3)
Blood Pressure Increased (3)
Skin Exfoliation (3)
Muscle Rigidity (3)
Headache (3)
Rash Maculo-papular (3)
Liver Disorder (3)
Loss Of Consciousness (3)
C-reactive Protein Increased (2)
Atrioventricular Block First Degree (2)
Blood Pressure Decreased (2)
Cardiac Arrest (2)
Dehydration (2)
Coronary Artery Occlusion (2)
Condition Aggravated (2)
Coronary Artery Stenosis (2)
Cardio-respiratory Arrest (2)
Atrioventricular Block Complete (2)
Dyspnoea (2)
Feeling Abnormal (2)
Sinoatrial Block (2)
Syncope (2)
Perivascular Dermatitis (2)
Aspartate Aminotransferase Increased (2)
Intentional Overdose (2)
Toxic Skin Eruption (2)
Nausea (2)
Transient Ischaemic Attack (2)
Acute Myocardial Infarction (2)
Alanine Aminotransferase Increased (2)
Traumatic Intracranial Haemorrhage (2)
Face Oedema (2)
Nephritis Interstitial (1)
Nervousness (1)
Neuropathy Peripheral (1)
Metabolic Encephalopathy (1)
Left Ventricular Failure (1)
Left Ventricular Dysfunction (1)
Lichenoid Keratosis (1)
Melaena (1)
Memory Impairment (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Citalopram caused me to suffer acute-closed angle Glaucoma CAG,

Diagnosis and treatment began at age 44 and the pressure was well controlled until the last two years at age 66. In 2003 I suffered a concussion along with other events which worsened depressive episodes. In 2004 I began Celexa an

HI, I HAVE BEEN TAKING TILDIEM FOR JUST OVER TWO WEEKS, NOW ANS FELT REALLY DIZZY ON THE WAY HOME FROM WORK YESTERDAY, I WAS TAKING A SLOW REALEASE NITRATE UNTIL SUNDAY, AND SAW MY GP MONDAY COMPLAINING OF REALLY BAD HEADACHES WHICH WERE UNBEARABLE,

I am taking mono-tildiem for the relaxation of my oespophagus because it is tight and causing reflux. I have been coughing for some time now. Is that a result of the drug? Thank you.

I have been taking Combigan and Lumigan drops for glaucoma since December but the best eye pressures I have had have been 18 and 19. My pressures have gone up to the mid 20s again and my eyes get very red sometimes - my eyes are dry and I think I ha

I have had over a few days and feeling in my right eye. It feels as if it has explosed and i feel that it is not sitting so forward now as my left eye. Please advise

I may have glaucoma but have not had the advanced exams for diagnosis yet. In the mean time I have been proscribed clonozapam, which specifies not taking the medication if you have glaucoma. Will taking this medication increase the risk of glaucoma w

I've been treated for glaucoma for over 25 yrs (I'm 69). Have had 2 laser procedures. Have been using Istalol and Alphagan and for over a year now have had atrocious red eyes and red circles around my eyes. Jus

My moms dog had his eye removed 3wks ago and is now shaking and not eating well ... surgery was due to glucoma he is 14yrs old anyone have same problem or any info?

Tiredness and weakness

Masculino 65 años, 6 meses com ganfort(1gota al dia)y krytantec(2gotas al dia)en OI con glaucoma y maculopatia, solo ojo rojo, algo de xerostomia. insomnio ligero.El OD ya con endofotocoagulacion y a

Age 49 sex Male Diagnosis Glaucoma (wide angel) Frequncy Twice daily weight 165 Other Medication None Dosage 1 drop in each eye. My experiance is Weak

Can eydrops, used to control glaucoma, such as azopt. cause a leision on the spine an then lead to severe tingling in the hands and feet

Can you take this medicine with glaucoma

Citalopram caused me to suffer acute-closed angle Glaucoma CAG,

DOES SURMONTIL CAUSE GLAUCOMA?

Hi my mother suffering from glaucoma and she is 52 yrs old.She also takes regular medicine for blood pressure.I want what side effects and measures we can take to avoid any further damage.thanks

I have been taking Combigan and Lumigan drops for glaucoma since December but the best eye pressures I have had have been 18 and 19. My pressures have gone up to the mid 20s again and my eyes get very red sometimes - my eyes are dry and I think I ha

I have been using otrivin for 20 years on a daily basis and as far as i know,im very healty!!!!! no glaucoma or anything else!!!! i feel absolutely great!

I have been using Otrivin for 24 years, daily. A couple of months ago i felt pain in my right eye and the eyedoctor gave me the diagnose Glaucoma.

Glaucoma Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma
Condition: Glaucoma
Intervention: Drug: Glaucoma medications (Timolol, Brimonidine, Dorzolamide, Brinzolamide)
Outcome Measures: Intraocular pressure after Ahmed valve implantation for Glaucoma;   rate of hypertensive phase after Ahmed valve implantation for Glaucoma
2 Recruiting AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma
Conditions: Glaucoma;   Glaucoma, Open Angle
Intervention: Device: AqueSys XEN 45 Glaucoma Implant
Outcome Measures: Proportion of subjects achieving a 20% or greater reduction in IOP from baseline on the same or less number of medications;   Mean change in IOP from baseline
3 Recruiting Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves
Conditions: Refractory Glaucoma;   Intractable Glaucoma
Interventions: Device: Silicone plate Ahmed Glaucoma Valve (Model FP7);   Device: Porous Plate Ahmed Glaucoma Valve (Model M4)
Outcome Measures: Change in Intraocular Pressure;   Anti-Glaucoma Medications;   Surgical Success
4 Recruiting Comparison of the Ahmed Glaucoma Valve FP7 and FP8 in Pediatric Glaucoma
Condition: Pediatric Glaucoma
Interventions: Device: FP7 Ahmed Glaucoma Drainage Implant;   Device: FP8 Glaucoma Drainage Implant
Outcome Measures: Position of the drainage implant plate;   As a secondary outcome, we evaluate the variation in IOP preoperative and postoperative.
5 Unknown  Direct Application of Selective Laser Trabeculoplasty Using the "DIO-DENT 10" in Open Angle Glaucoma
Condition: Glaucoma
Interventions: Device: Direct application of Selective Laser Trabeculoplasty;   Device: Direct application of SLT in Open Angle Glaucoma
Outcome Measure: Reduction of Intra-Ocular pressure
6 Recruiting Functional and Structural Imaging for Glaucoma
Condition: Glaucoma
Intervention:
Outcome Measure: Developing Glaucoma or progression with Glaucoma as defined by study criteria
7 Unknown  Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma
Condition: Refractory Glaucoma
Interventions: Drug: Subconjunctival Avastin;   Device: Ahmed Valve implant
Outcome Measures: Change in intraocular pressure (IOP);   Surgical failure;   Change in intraocular pressure
8 Unknown  Corneal Endothelium After Glaucoma Surgery
Conditions: Glaucoma;   Corneal Damage;   Intraocular Pressure
Intervention:
Outcome Measures: Change in corneal endothelial cell density, hexagonality, and coefficient of variation of cell area;   Clinical factors associated with the damage of corneal endothelium after Glaucoma surgery
9 Unknown  Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma
Condition: Refractory Glaucoma
Interventions: Device: Ahmed Glaucoma Valve (AGV);   Drug: Mitomycin C (MMC);   Procedure: amniotic membrane coverage
Outcome Measure:
10 Unknown  The Genetic Characteristics in South Korean Patients With Primary Congenital Glaucoma
Condition: Primary Congenital Glaucoma
Intervention:
Outcome Measures: clinical parameters of primary congenital Glaucoma (age, onset time, symptom, intraocular pressure, corneal diameter, cup to disc ratio, axial length, treatment type);   clinical parameters of primary congenital Glaucoma (age, onset time, symptom, intraocular pressure, corneal diameter, cup to disc ratio, refraction, axial length, treatment type)
11 Recruiting Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma
Condition: Glaucoma
Intervention: Device: Artificial drainage implant
Outcome Measures: Intra Ocular Pressure (IOP);   Success rate;   Number of patients with adverse events as a measure of safety
12 Recruiting Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study
Conditions: Open Angle Glaucoma;   Normal Tension Glaucoma
Intervention:
Outcome Measures: Choroidal thickness correlation with short ciliary arteries blood flow velocities;   Comparison of the Retrobulbar Arteries Doppler Waveform between Glaucoma patients and healthy controls
13 Unknown  Protective Effect of Phenytoin on Glaucoma
Conditions: Primary Open Angle Glaucoma;   Secondary Open Angle Glaucoma;   Narrow-Angle Glaucomas;   Normal Tension Glaucoma
Intervention:
Outcome Measures: peripapillary RNFL thickness;   corrected pattern standard deviation in perimetric visual field
14 Recruiting Structure Function Correlation in Primary Open Angle Glaucoma
Condition: Primary Open Angle Glaucoma
Intervention:
Outcome Measures: Correlation between retinal nerve fibre layer thickness measured by optical coherence tomography and mean sensitivity, mean deviation as reported by visual fields.;   Correlation between retinal nerve fibre layer thinning and scotomatous defects in visual fields in primary open angle Glaucoma.
15 Unknown  Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.
Condition: Glaucoma
Intervention: Device: Susanna Implant
Outcome Measures: Study clinical multicenter, phase III, open-label, prospective character to evaluate the efficacy and safety Susanna implant in patients with refractory Glaucoma.;   Study clinical multicenter, phase III, open-label, prospective character to evaluate the efficacy and safety Susanna implant in patients with refractory Glaucoma. "
16 Recruiting Myocilin Variations and Familial Glaucoma in Taxiarchis
Condition: Glaucoma
Intervention:
Outcome Measure: Examining all of the villagers to determine the actual incidence of Glaucoma in Taxiarchis and identify the Thr377Met myocilin mutation in Glaucoma patients.
17 Not yet recruiting Use of a Human Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With Glaucoma
Condition: Glaucoma
Intervention: Device: HOCD
Outcome Measures: Estimated contrast sensitivity in log units;   Distinguish patients with and without Glaucoma (statistically different log units of contrast sensitivity);   Compare contrast sensitivity measured with the HOCD (log units of contrast sensitivity) to white on white sensitivity (in decibels) via automated perimetry;   Compare contrast sensitivity measured with the HOCD (log units of contrast sensitivity) to contrast sensitivity testing (log units of contrast sensitivity) via Pelli Robson Contrast Sensitivity Chart testing.
18 Recruiting Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
Condition: Open-angle Glaucoma
Interventions: Device: iStent inject;   Drug: Travoprost
Outcome Measures: Change from screening in mean diurnal IOP (mm Hg) at the Month 12 visit.;   Change in mean diurnal IOP vs. screening;   Change in screening in time-wise IOPs;   Proportion of responders
19 Recruiting Advanced Glaucoma Progression Study
Conditions: Primary Open Angle Glaucoma;   Pseudoexfoliative Glaucoma;   Chronic Angle Closure Glaucoma
Intervention:
Outcome Measures: Visual field progression;   Worsening of OCT measurements;   Contrast sensitivity
20 Not yet recruiting Timing of Glaucoma Drainage Device With Boston KPro Surgery
Conditions: Corneal Diseases;   Corneal Opacity
Interventions: Device: Boston keratoprosthesis type 2;   Device: Glaucoma drainage device
Outcome Measures: Visual field mean deviation;   Disc Damage Likelihood Scale (DDLS) on clinical examination;   Disc Damage Likelihood Scale (DDLS) on stereoscopic photographs of the optic nerve;   Ocular complications;   Visual acuity